Related content

Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK

By Beard S. M.   McCrink L.   Le T. K.   Garcia-Cebrian A.   Monz B.   Malik R. A.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 385-399

Informa Healthcare

Access to resources Recommend Favorite

Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States

By  

PAIN MEDICINE, Vol. 16, Iss. 11, 2015-11 ,pp. : 2075-2083

John Wiley & Sons Inc

Access to resources Recommend Favorite

External Noninvasive Peripheral Nerve Stimulation Treatment of Neuropathic Pain: A Prospective Audit

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 18, Iss. 5, 2015-07 ,pp. : 384-391

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients

By  

Current Drug Safety, Vol. 4, Iss. 1, 2009-01 ,pp. : 22-29

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain

By Treede R.-D.   Wagner T.   Kern K.-U.   Husstedt I.W.   Arendt G.   Birklein F.   Cegla T.   Freynhagen R.   Gockel H.-H.   Heskamp M.-L.   Jager H.   Joppich R.   Maier C.   Leffler A.   Nagelein H.-H.   Rolke R.   Seddigh S.   Sommer C.   Stander S.   Wasner G.   Baron R.  

Current Medical Research and Opinion, Vol. 29, Iss. 5, 2013-05 ,pp. : 527-538

Informa Healthcare

Access to resources Recommend Favorite